ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 55 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $53,000 | -28.4% | 253,300 | -16.5% | 0.00% | -50.0% |
| Q2 2022 | $74,000 | -14.9% | 303,300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $87,000 | -48.8% | 303,300 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $170,000 | -63.4% | 303,300 | -33.5% | 0.00% | -66.7% |
| Q3 2021 | $465,000 | -33.9% | 456,000 | -10.5% | 0.01% | -30.8% |
| Q2 2021 | $703,000 | -38.0% | 509,250 | -23.6% | 0.01% | -38.1% |
| Q1 2021 | $1,133,000 | +208.7% | 666,350 | +125.0% | 0.02% | +162.5% |
| Q4 2020 | $367,000 | -20.7% | 296,150 | -9.2% | 0.01% | -27.3% |
| Q3 2020 | $463,000 | +10.5% | 326,150 | -5.8% | 0.01% | +37.5% |
| Q2 2020 | $419,000 | +2.7% | 346,150 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $408,000 | -44.1% | 346,150 | 0.0% | 0.01% | -10.0% |
| Q4 2019 | $730,000 | -4.2% | 346,150 | 0.0% | 0.01% | -9.1% |
| Q3 2019 | $762,000 | -13.0% | 346,150 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $876,000 | -27.3% | 346,150 | 0.0% | 0.01% | -26.7% |
| Q1 2019 | $1,205,000 | +50.6% | 346,150 | 0.0% | 0.02% | +36.4% |
| Q4 2018 | $800,000 | -40.0% | 346,150 | 0.0% | 0.01% | -15.4% |
| Q3 2018 | $1,333,000 | +60.4% | 346,150 | +40.6% | 0.01% | +62.5% |
| Q2 2018 | $831,000 | +41.8% | 246,150 | -11.8% | 0.01% | +33.3% |
| Q1 2018 | $586,000 | +3.7% | 279,150 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $565,000 | -61.5% | 279,150 | -12.5% | 0.01% | -64.7% |
| Q3 2017 | $1,468,000 | +114.0% | 319,150 | 0.0% | 0.02% | +112.5% |
| Q2 2017 | $686,000 | -10.8% | 319,150 | +30.7% | 0.01% | -11.1% |
| Q1 2017 | $769,000 | +5.1% | 244,150 | -13.3% | 0.01% | -10.0% |
| Q4 2016 | $732,000 | -33.2% | 281,650 | 0.0% | 0.01% | -37.5% |
| Q3 2016 | $1,096,000 | +44.6% | 281,650 | 0.0% | 0.02% | +33.3% |
| Q2 2016 | $758,000 | +10.2% | 281,650 | +26.1% | 0.01% | 0.0% |
| Q1 2016 | $688,000 | +76.4% | 223,400 | +120.5% | 0.01% | +71.4% |
| Q4 2015 | $390,000 | +26.2% | 101,300 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $309,000 | -28.1% | 101,300 | 0.0% | 0.01% | -25.0% |
| Q2 2015 | $430,000 | +10.0% | 101,300 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $391,000 | -42.7% | 101,300 | 0.0% | 0.01% | -50.0% |
| Q4 2014 | $682,000 | +26.8% | 101,300 | +3.4% | 0.02% | +14.3% |
| Q3 2014 | $538,000 | -46.5% | 98,000 | 0.0% | 0.01% | -46.2% |
| Q2 2014 | $1,005,000 | -20.2% | 98,000 | -6.5% | 0.03% | -27.8% |
| Q1 2014 | $1,259,000 | -1.3% | 104,820 | -7.1% | 0.04% | -7.7% |
| Q4 2013 | $1,276,000 | +4.4% | 112,800 | -0.5% | 0.04% | -7.1% |
| Q3 2013 | $1,222,000 | +16.8% | 113,400 | +0.5% | 0.04% | 0.0% |
| Q2 2013 | $1,046,000 | – | 112,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |